Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8+ T cells and associated with a proliferative response to p24 antigen

Journal of Virology

Volumn 74, Issue 4, 2000, Pages 2023-2028

  De Quiros, Juan Carlos Lopez Bernaldo ^a,b,c   Shupert, W Lesley ^c   McNeil, Andrew C ^c   Gea Banacloche, Juan C ^c   Flanigan, Mark ^c   Savage, Ann ^c   Martino, Lisa ^c   Weiskopf, Emma E ^c   Imamichi, Hiromi ^d   Zhang, Yi Ming ^d   Adelsburger, Joseph ^d   Stevens, Randy ^d   Murphy, Philip M ^c   Zimmerman, Peter A ^c   Hallahan, Claire W ^c   Davey Jr , Richard T ^c   Connors, Mark ^c,e  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d SAIC FREDERICK INC   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD8 ANTIGEN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS RESISTANCE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL TRANSPLANTATION; DISEASE PROGRESSION; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; IMMUNITY, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, SCID; VIRUS REPLICATION;

EID: 0033934286     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.4.2023-2028.2000     Document Type: Article

References (37)

1. Alexander-Miller, M. A., G. R. Leggatt, and J. A. Berzofsky. 1996. Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. USA 93:4102-4107.
2. Barker, E., C. E. Mackewicz, G. Reyes-Teran, A. Sato, S. A. Stranford, S. H. Fujimura, C. Christopherson, S. Y. Chang, and J. A. Levy. 1998. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 92: 3105-3114.
3. Barker, T. D., D. Weissman, J. A. Daucher, K. M. Roche, and A. S. Fauci. 1996. Identification of multiple and distinct CDK+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation. J. Immunol. 156:4476-4483.
4. Bennett, S. R., F. R. Carbone, F. Karamalis, J. F. Miller, and W. R. Heath. 1997. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med. 186:65-70.
5. Boyle, M. J., M. Connors, M. E. Flanigan, S. P. Geiger. H. Ford, Jr., M. Baseler, J. Adelsberger, R. T. Davey, Jr., and H. C. Lane. 1995. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy. J. Immunol. 154:6612-6623.
6. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
7. Cohen, O. J., A. Kinter, and A. S. Fauci. 1997. Host factors in the pathogenesis of HIV disease. Immunol. Rev. 159:31-48.
8. + responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J. Virol. 73:7108-7116.
9. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, et al. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
10. Dittmer, U., T. Nisslein, W. Bodemer, H. Petry, U. Sauermann, C. Stahl-Hennig, and G. Hunsmann. 1995. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392-397.
11. Dittmer, U., M. Spring, H. Petry, T. Nisslein, P. Rieckmann, W. Luke, C. Stahl-Hennig, G. Hunsmann, and W. Bodemer. 1996. Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV). J. Biotechnol. 44:105-110.
12. Ferbas, J., A. H. Kaplan, M. A. Hausner, L. E. Hultin, J. L. Matud, Z. Liu, D. L. Panicali, H. Nerng-Ho, R. Detels, and J. V. Giorgi. 1995. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J. Infect. Dis. 172: 329-339.
13. Gulizia, R. J., R. G. Collman, J. A. Levy, D. Trono, and D. E. Mosier. 1997. Deletion of nef slows hut does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice. J. Virol. 71:416-4164.
14. Han, W. R., P. L. Mottram, L. J. Purcell I, R. J. Plenter, and I. F. C. McKenzie. 1995. Infiltrating cells in mouse cardiac allografts after anti-CD4 monoclonal antibody treatment. Transplant. Proc. 27:2163.
15. Harrer, T., E. Harrer, S. A. Kalams, T. Elbeik, S. I. Staprans, M. B. Feinberg, Y. Cao, D. D. Ho, T. Yilma, A. M. Caliendo, R. P. Johnson, S. P. Buchbinder, and B. D. Walker. 1996. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retrovirus. 12:585-592.
16. Jin, X., D. E. Bauer, S. E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C. E. Irwin, J. T. Safrit, J. Mittler, L. Weinberger, L. G. Kostrikis, L. Zhang, A. S. Perelson, and D. D. Ho. 1999. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-998.
17. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301-8309.
18. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof Garde, R. J. Bende, I. P. Keet, J. K. Eeftinck-Schattenkerk, A. D. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365-1372.
19. Krieger, N. R., D. P. Yin, and C. G. Fathman. 1996. CD4+ but not CD8+ cells are essential for allorejection. J. Exp. Med. 184:2013-2018.
20. Kurts, C., F. R. Carbone, M. Barnden, E. Blanas, J. Allison, W. R. Heath, and J. F. Miller. 1997. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186:2057-2062.
21. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson, S. Swetter, J. Thompson, P. D. Greenberg, M. Roederer, and M. M. Davis. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:677-685.
22. Lefrere, J. J., M. Mariotti, L. Morand-Joubert, M. Thauvin, and F. Roudot-Thoraval. 1999. Plasma human immunodeficiency virus RNA below 40 copies/mL is rare in untreated persons even in the first years of infection. J. Infect. Dis. 180:526-529.
23. Lefrere, J. J., L. Morand-Joubert, M. Mariotti, H. Bludau, B. Burghoffer, J. C. Petit, and F. Roudot-Thoraval. 1997. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. Blood 90:1133-1140.
24. Matano, T., R. Shibata, C. Siemon, M. Connors, H. C. Lane, and M. A. Martin. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:164-169.
25. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
26. Mosier, D. E., R. J. Gulizia, S. M. Baird, D. B. Wilson, D. H. Spector, and S. A. Spector. 1991. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251:791-794.
27. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. J. Schrager, J. B. Margolick, S. Buchbinder, J. V. Giorgi, and A. S. Fauci. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
28. Picchio, G. R., R. J. Gulizia, and D. E. Mosier. 1997. Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice. J. Virol. 71:7124-7127.
29. Pilgrim, A. K., G. Pantaleo, O. J. Cohen, L. M. Fink, J. Y. Zhou, J. T. Zhou, D. P. Bolognesi, A. S. Fauci, and D. C. Montefiori. 1997. Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176:924-932.
30. Pontesilli, O., P. Carotenuto, S. R. Kerkhof-Garde, M. T. Roos, I. P. Keet, R. A. Coutinho, J. Goudsmit, and F. Miedema. 1999. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection. AIDS Res. Hum. Retrovirus. 15:973-981.
31. Rinaldo, C., P. Piazza, Y. Z. Wang, J. Armstrong, P. Gupta, M. Ho, S. Petteway, D. Reed, D. Lyter, and L. Kingsley. 1988. HIV-1-specific production of IFN-gamma and modulation by recombinant IL-2 during early HIV-1 infection. J. Immunol. 140:3389-3393.
32. Rinaldo, C. R., Jr., L. A. Beltz, X. L. Huang, P. Gupta, Z. Fan, and D. J. Torpey III. 1995. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. AIDS Res. Hum. Retrovirus. 11:481-489.
33. Rosenberg, E. S., J. M. Billingsley, A. M. Caliendo, S. L. Boswell, P. E. Sax, S. A. Kalams, and B. D. Walker. 1997. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 278:1447-1450.
34. Schmitz, J. E., M. J. Kuroda. S. Santra, V. G. Sasseville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, J. Ghrayeb, M. A. Forman, D. C. Montefiori, E. P. Rieber, N. L. Letvin, and K. A. Reimann. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860.
35. Strathdee, S. A., P. J. Veugelers, K. A. Page-Shafer, A. McNulty, A. R. Moss, M. T. Schechter, G. J. van Griensven, and R. A. Coutinho. 1996. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS 10:959-965.
36. Vesanen, M., C. E. Stevens, P. E. Taylor, P. Rubinstein, and K. Saksela. 1996. Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J. Virol. 70:9035-9040.
37. Walker, B. D. 1990. Techniques in HIV research. Stockton Press, New York, N.Y.